相关实验视频
Updated: Jun 13, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
原子人工酶治疗急性和慢性肺炎
Wei Liu1,2, Di Liu1, Tianyi Cui3
1Tianjin Key Laboratory of Brain Science and Neural Engineering, Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China.
黄金纳米集群 (AuNCs) 显示出作为人工酶治疗肺炎等肺部疾病的承诺,通过模仿自然酶来减少氧化应激和炎症,提供稳定和经济有效的替代方案.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 肺炎带来复杂的免疫挑战,有效治疗方法有限.
- 自然酶为氧化应激提供治疗潜力,但在稳定性和成本方面存在局限性.
- 黄金纳米集群 (AuNCs) 被探索为稳定,生物活性的人造酶用于肺损伤.
研究的目的:
- 调查黄金纳米集群 (AuNCs) 作为下一代急性肺损伤 (ALI) 和过敏性肺病 (ALD) 的生物剂的潜力.
- 在肺炎的临床前模型中评估Au NCs的酶活性,稳定性和治疗疗效.
主要方法:
- 金纳米集群 (AuNCs) 的合成和表征,特别是Au25和Au24Er1.
- 在体外评估Au NCs的催化酶 (CAT) 和谷氨过氧化酶 (GPx) 仿真活性.
- 评估AuNCs对线粒体氧化应激和三酸氨酸 (ATP) 合成的影响.
- 在体内研究使用急性肺损伤 (ALI) 和卵胺诱导过敏肺病 (ALD) 的小鼠模型.
- 分析分子机制,包括TLR4/MyD88/NF-κB通路和巨细胞两极分化.
主要成果:
- AuNCs表现出显著的甲酶和谷氨过氧化酶类活性,Au24Er1对H2O2的亲和力比自然CAT更高.
- NCs有效抑制了线粒体的氧化应激,并促进了ATP合成.
- 用AuNCs治疗抑制了ALI中的TLR4/MyD88/NF-κB通路和M1巨反应.
- 在过敏性肺病模型中,Au NCs挽救了Th1/Th2不平衡.
- 在AUNC治疗后,ALI和ALD模型中的肺功能显著改善.
结论:
- 金纳米集群 (AuNCs) 具有强大的抗炎和抗氧化特性,使其在肺损伤的临床前模型中有效.
- NC作为天然酶的可行替代品,提供增强的稳定性和治疗包括肺炎在内的各种肺部疾病的潜力.
- 这些发现突出了Au NC作为免疫调节和肺损伤治疗干预的有希望的生物制药.
更多相关视频
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia II: Pathophysiology
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...